Paolucci S - Search Results

1

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Di Maio VC, Cento V, Aragri M, Paolucci S, Pollicino T, Coppola N, Bruzzone B, Ghisetti V, Zazzi M, Brunetto M, Bertoli A, Barbaliscia S, Galli S, Gennari W, Baldanti F, Raimondo G, Perno CF, Ceccherini-Silberstein F; HCV Virology Italian Resistance Network (VIRONET-C). Di Maio VC, et al. Among authors: paolucci s. J Hepatol. 2018 Mar;68(3):597-600. doi: 10.1016/j.jhep.2017.09.008. Epub 2017 Sep 20. J Hepatol. 2018. PMID: 28939133 No abstract available.

2

Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy.

Baldanti F, Paolucci S, Parisi A, Meroni L, Gerna G. Baldanti F, et al. Among authors: paolucci s. Clin Infect Dis. 2002 Apr 15;34(8):1146-9. doi: 10.1086/339750. Epub 2002 Mar 19. Clin Infect Dis. 2002. PMID: 11915006

3

Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients.

Paolucci S, Baldanti F, Zavattoni M, Comolli G, Labò N, Menzo S, Clementi M, Gerna G. Paolucci S, et al. J Antimicrob Chemother. 2003 Jan;51(1):135-9. doi: 10.1093/jac/dkg016. J Antimicrob Chemother. 2003. PMID: 12493798

4

Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy.

Paolucci S, Baldanti F, Tinelli M, Maga G, Gerna G. Paolucci S, et al. AIDS. 2003 Apr 11;17(6):924-7. doi: 10.1097/00002030-200304110-00022. AIDS. 2003. PMID: 12660544 No abstract available.

5

Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine.

Baldanti F, Paolucci S, Maga G, Labo N, Hübscher U, Skoblov AY, Victorova L, Spadari S, Minoli L, Gerna G. Baldanti F, et al. Among authors: paolucci s. AIDS. 2003 Jul 4;17(10):1568-70. doi: 10.1097/00002030-200307040-00021. AIDS. 2003. PMID: 12824799

6

Novel recombinant phenotypic assay for clonal analysis of reverse transcriptase mutations conferring drug resistance to HIV-1 variants.

Paolucci S, Baldanti F, Zavattoni M, Gerna G. Paolucci S, et al. J Antimicrob Chemother. 2004 May;53(5):766-71. doi: 10.1093/jac/dkh165. Epub 2004 Mar 24. J Antimicrob Chemother. 2004. PMID: 15044427

7

Assays for determination of HIV resistance to antiviral drugs.

Baldanti F, Paolucci S, Dossena L, Gerna G. Baldanti F, et al. Among authors: paolucci s. Curr Drug Metab. 2004 Aug;5(4):317-9. doi: 10.2174/1389200043335496. Curr Drug Metab. 2004. PMID: 15320703 Review.

8

Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replication.

Paolucci S, Baldanti F, Maga G, Cancio R, Zazzi M, Zavattoni M, Chiesa A, Spadari S, Gerna G. Paolucci S, et al. Antimicrob Agents Chemother. 2004 Dec;48(12):4611-7. doi: 10.1128/AAC.48.12.4611-4617.2004. Antimicrob Agents Chemother. 2004. PMID: 15561833 Free PMC article.

Several amino acid substitutions different from the recently reported Gln145Met change (S. Paolucci, F. Baldanti, M. Tinelli, G. Maga, and G. Gerna, AIDS 17:924-927, 2003) were detected at position 145. ...

Several amino acid substitutions different from the recently reported Gln145Met change (S. Paolucci, F. Baldanti, M. Tinelli, …

9

Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital.

Rovida F, Percivalle E, Zavattoni M, Torsellini M, Sarasini A, Campanini G, Paolucci S, Baldanti F, Revello MG, Gerna G. Rovida F, et al. Among authors: paolucci s. J Med Virol. 2005 Feb;75(2):336-47. doi: 10.1002/jmv.20276. J Med Virol. 2005. PMID: 15602736 Free PMC article.

10

Amino acid insertions at position 35 of HIV-1 protease interfere with virus replication without modifying antiviral drug susceptibility.

Paolucci S, Baldanti F, Dossena L, Gerna G. Paolucci S, et al. Antiviral Res. 2006 Mar;69(3):181-5. doi: 10.1016/j.antiviral.2005.12.005. Epub 2006 Jan 20. Antiviral Res. 2006. PMID: 16460817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page